These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35744960)

  • 1. Potential Application of Gambogic Acid for Retarding Renal Cyst Progression in Polycystic Kidney Disease.
    Khunpatee N; Bhukhai K; Chatsudthipong V; Yuajit C
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chalcone derivative retards renal cyst enlargement by inhibiting fluid secretion and cell proliferation in an in vitro model of polycystic kidney disease.
    Veeraphan P; Chavasiri W; Muanprasat C; Chatsudthipong V; Yuajit C
    Clin Exp Nephrol; 2021 Sep; 25(9):944-952. PubMed ID: 34057612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganoderic acid A is the effective ingredient of Ganoderma triterpenes in retarding renal cyst development in polycystic kidney disease.
    Meng J; Sai-Zhen Wang ; He JZ; Zhu S; Huang BY; Wang SY; Li M; Zhou H; Lin SQ; Yang BX
    Acta Pharmacol Sin; 2020 Jun; 41(6):782-790. PubMed ID: 31911637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease.
    Sundar SV; Zhou JX; Magenheimer BS; Reif GA; Wallace DP; Georg GI; Jakkaraj SR; Tash JS; Yu ASL; Li X; Calvet JP
    Am J Physiol Renal Physiol; 2022 Oct; 323(4):F492-F506. PubMed ID: 35979967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological Effects of Panduratin A on Renal Cyst Development in In Vitro and In Vivo Models of Polycystic Kidney Disease.
    Tonum K; Srimai N; Chabang N; Fongsupa S; Tuchinda P; Torres JA; Weimbs T; Soodvilai S
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steviol retards renal cyst growth through reduction of CFTR expression and inhibition of epithelial cell proliferation in a mouse model of polycystic kidney disease.
    Yuajit C; Muanprasat C; Gallagher AR; Fedeles SV; Kittayaruksakul S; Homvisasevongsa S; Somlo S; Chatsudthipong V
    Biochem Pharmacol; 2014 Apr; 88(3):412-21. PubMed ID: 24518257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin inhibits renal cyst growth in vitro and via parenteral injection in a polycystic kidney disease mouse model.
    Zhu Y; Teng T; Wang H; Guo H; Du L; Yang B; Yin X; Sun Y
    Food Funct; 2018 Jan; 9(1):389-396. PubMed ID: 29215110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardamonin retards progression of autosomal dominant polycystic kidney disease via inhibiting renal cyst growth and interstitial fibrosis.
    He J; Zhou H; Meng J; Zhang S; Li X; Wang S; Shao G; Jin W; Geng X; Zhu S; Yang B
    Pharmacol Res; 2020 May; 155():104751. PubMed ID: 32151678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginkgolide B inhibits renal cyst development in in vitro and in vivo cyst models.
    Zhou H; Gao J; Zhou L; Li X; Li W; Li X; Xia Y; Yang B
    Am J Physiol Renal Physiol; 2012 May; 302(10):F1234-42. PubMed ID: 22338085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inositol 1,4,5-triphosphate receptor 3 promotes renal cyst development in autosomal dominant polycystic kidney disease].
    Qiu ZW; Liu M; Zhou H; Yang BX
    Sheng Li Xue Bao; 2023 Jun; 75(3):328-338. PubMed ID: 37340642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obacunone Retards Renal Cyst Development in Autosomal Dominant Polycystic Kidney Disease by Activating NRF2.
    Qiu Z; He J; Shao G; Hu J; Li X; Zhou H; Li M; Yang B
    Antioxidants (Basel); 2021 Dec; 11(1):. PubMed ID: 35052542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin inhibits renal cyst formation and enlargement in vitro by regulating intracellular signaling pathways.
    Gao J; Zhou H; Lei T; Zhou L; Li W; Li X; Yang B
    Eur J Pharmacol; 2011 Mar; 654(1):92-9. PubMed ID: 21187084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CaMK4 overexpression in polycystic kidney disease promotes mTOR-mediated cell proliferation.
    Zhang Y; Daniel EA; Metcalf J; Dai Y; Reif GA; Wallace DP
    J Mol Cell Biol; 2022 Sep; 14(7):. PubMed ID: 36002021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Potential Application of Chitosan Oligosaccharide for Attenuation of Renal Cyst Growth in the Treatment of Polycystic Kidney Disease.
    Pathomthongtaweechai N; Soodvilai S; Pichyangkura R; Muanprasat C
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33261193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HL156A, an AMP-Activated Protein Kinase Activator, Inhibits Cyst Growth in Autosomal Dominant Polycystic Kidney Disease.
    Seo S; Kim H; Hwang JT; Kim JE; Kim J; Jeon S; Song YJ; Choi KH; Sim G; Cho M; Yoon JW; Kim H
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steviol slows renal cyst growth by reducing AQP2 expression and promoting AQP2 degradation.
    Noitem R; Yuajit C; Soodvilai S; Muanprasat C; Chatsudthipong V
    Biomed Pharmacother; 2018 May; 101():754-762. PubMed ID: 29524884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lansoprazole reduces renal cyst in polycystic kidney disease via inhibition of cell proliferation and fluid secretion.
    Nantavishit J; Chatsudthipong V; Soodvilai S
    Biochem Pharmacol; 2018 Aug; 154():175-182. PubMed ID: 29746821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pinostrobin inhibits renal CFTR-mediated Cl
    Tonum K; Chabang N; Fongsupa S; Chantawarin S; Jiarpinitnun C; Tuchinda P; Soodvilai S
    J Pharmacol Sci; 2022 Apr; 148(4):369-376. PubMed ID: 35300812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease.
    Jamadar A; Suma SM; Mathew S; Fields TA; Wallace DP; Calvet JP; Rao R
    Cell Death Dis; 2021 Oct; 12(10):947. PubMed ID: 34650051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone inhibits insulin-like growth factor‑1-induced polycystic kidney disease cell growth and p70S6 kinase activation.
    Liu C; Zhang Y; Yuan L; Fu L; Mei C
    Mol Med Rep; 2013 Sep; 8(3):861-4. PubMed ID: 23864113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.